Skip to content
10-Q

Quarterly Report

NIAGEN BIOSCIENCE, INC. NAGE

0001386570-26-000030

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 4, 2026 79.64M sh
Shares Diluted Q1 2026 · Mar 31, 2026 84.57M sh
Shares Diluted Q1 2026 · Mar 31, 2025 83.23M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $2.35M
Stock Repurchased Q1 2026 · Mar 31, 2025 $0
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$1.19M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $7.88M
Stockholders Equity Q1 2026 · Mar 31, 2026 $82.33M
Stockholders Equity Q1 2026 · Dec 31, 2025 $76.53M
Stockholders Equity Q1 2026 · Mar 31, 2025 $55.35M
Stockholders Equity Q1 2026 · Dec 31, 2024 $46.09M
Current Liabilities Q1 2026 · Mar 31, 2026 $22.82M
Current Liabilities Q1 2026 · Dec 31, 2025 $19.92M
Total Liabilities Q1 2026 · Mar 31, 2026 $32M
Total Liabilities Q1 2026 · Dec 31, 2025 $29.87M
Current Assets Q1 2026 · Mar 31, 2026 $105.12M
Current Assets Q1 2026 · Dec 31, 2025 $96.81M
Total Assets Q1 2026 · Mar 31, 2026 $114.33M
Total Assets Q1 2026 · Dec 31, 2025 $106.41M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.07
Eps Diluted Q1 2026 · Mar 31, 2025 $0.06
Eps Basic Q1 2026 · Mar 31, 2026 $0.08
Eps Basic Q1 2026 · Mar 31, 2025 $0.07
Sga Expense Q1 2026 · Mar 31, 2026 $7.24M
Sga Expense Q1 2026 · Mar 31, 2025 $5.18M
Rd Expense Q1 2026 · Mar 31, 2026 $1.48M
Rd Expense Q1 2026 · Mar 31, 2025 $1.26M
Net Income Q1 2026 · Mar 31, 2026 $6.32M
Net Income Q1 2026 · Mar 31, 2025 $5.06M
Operating Income Q1 2026 · Mar 31, 2026 $1.58M
Operating Income Q1 2026 · Mar 31, 2025 $4.77M
Gross Profit Q1 2026 · Mar 31, 2026 $19.98M
Gross Profit Q1 2026 · Mar 31, 2025 $19.33M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $11.5M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $11.15M
Revenue Q1 2026 · Mar 31, 2026 $31.47M
Revenue Q1 2026 · Mar 31, 2025 $30.48M